Table of Contents 2012-2023 Global Diabetic Therapeutic Drugs Market Research Report by Manufacturers, Regions, Types and Applications 1 Diabetic Therapeutic Drugs Market Overview 1.1 Product Overview and Scope of Diabetic Therapeutic Drugs 1.2 Diabetic Therapeutic Drugs Segment by Type (Product Category) 1.2.1 Diabetic Therapeutic Drugs Segment by Types (Product Category) and Its Subclasses 1.2.2 Global Diabetic Therapeutic Drugs Production Market Share by Type (Product Category) in 2016 1.2.3 Different Subclasses for Insulin Therapies 1.2.3.1 Subclass 1 1.2.3.2 Subclass 2 1.2.3.3 Subclass 3 1.2.4 Different Subclasses for Non-Insulin Therapies 1.2.4.1 Subclass 1 1.2.4.2 Subclass 2 1.2.4.3 Subclass 3 1.3 Global Diabetic Therapeutic Drugs Segment by Application 1.3.1 Global Diabetic Therapeutic Drugs Consumption (K Units) Comparison by Applications (2012-2023) 1.3.2 Type 1 Diabetes 1.3.3 Type 2 Diabetes 1.3.4 Gestational Diabetes 1.4 New Project SWOT Analysis of Diabetic Therapeutic Drugs 1.5 Industry News Analysis of Diabetic Therapeutic Drugs 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Diabetic Therapeutic Drugs 2.2 Raw Material Analysis of Diabetic Therapeutic Drugs 2.2.1 Raw Material A Market Analysis 2.2.2 Raw Material B Market Analysis 2.2.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Diabetic Therapeutic Drugs 2.4 Other Costs Analysis of Diabetic Therapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs 2.6 Manufacturing Process Analysis of Diabetic Therapeutic Drugs 2.7 Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2017 2.8 Downstream Buyers of Diabetic Therapeutic Drugs 3 Global Diabetic Therapeutic Drugs Manufacturers Profiles/Analysis 3.1 Pfizer 3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.1.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.1.2.1 Insulin Therapies 3.1.2.2 Non-Insulin Therapies 3.1.3 Pfizer Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Pfizer Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Pfizer Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.2 Novartis 3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.2.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.2.2.1 Insulin Therapies 3.2.2.2 Non-Insulin Therapies 3.2.3 Novartis Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Novartis Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Novartis Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.3 AstraZeneca 3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.3.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.3.2.1 Insulin Therapies 3.3.2.2 Non-Insulin Therapies 3.3.3 AstraZeneca Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 AstraZeneca Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 AstraZeneca Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Eli Lilly 3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.4.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.4.2.1 Insulin Therapies 3.4.2.2 Non-Insulin Therapies 3.4.3 Eli Lilly Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Eli Lilly Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Eli Lilly Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Merck 3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.5.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.5.2.1 Insulin Therapies 3.5.2.2 Non-Insulin Therapies 3.5.3 Merck Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Merck Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Merck Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Novo Nordisk 3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.6.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.6.2.1 Insulin Therapies 3.6.2.2 Non-Insulin Therapies 3.6.3 Novo Nordisk Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Novo Nordisk Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Novo Nordisk Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Sanofi 3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.7.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.7.2.1 Insulin Therapies 3.7.2.2 Non-Insulin Therapies 3.7.3 Sanofi Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Sanofi Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Sanofi Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.8 F. Hoffmann-La Roche 3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.8.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.8.2.1 Insulin Therapies 3.8.2.2 Non-Insulin Therapies 3.8.3 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 F. Hoffmann-La Roche Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.9 Takeda Pharmaceuticals 3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.9.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.9.2.1 Insulin Therapies 3.9.2.2 Non-Insulin Therapies 3.9.3 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Takeda Pharmaceuticals Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.10 Sun Pharma 3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors 3.10.2 Diabetic Therapeutic Drugs Product Category, Application and Specification 3.10.2.1 Insulin Therapies 3.10.2.2 Non-Insulin Therapies 3.10.3 Sun Pharma Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 Sun Pharma Different Types of Diabetic Therapeutic Drugs Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 Sun Pharma Diabetic Therapeutic Drugs Volume in Different Applications and Its Application Share 3.11 Perle Biosciences 3.12 Arbutus Biopharma 3.13 Belrose Pharma 3.14 Mitsubishi Tanabe Pharma 3.15 Dong-A ST 4 Global Diabetic Therapeutic Drugs Market Competition by Manufacturers 4.1 Global Diabetic Therapeutic Drugs Capacity, Production and Share by Manufacturers (2012-2017) 4.1.1 Global Diabetic Therapeutic Drugs Capacity (K Units) and Share (%) by Manufacturers (2012-2017) 4.1.2 Global Diabetic Therapeutic Drugs Production (K Units) and Share (%) by Manufacturers (2012-2017) 4.2 Global Diabetic Therapeutic Drugs Revenue (Million USD) and Share (%) by Manufacturers (2012-2017) 4.3 Global Diabetic Therapeutic Drugs Average Price (USD/Unit) by Manufacturers (2012-2017) 4.4 Manufacturers Diabetic Therapeutic Drugs Manufacturing Base Distribution, Sales Area, Product Types 4.5 Diabetic Therapeutic Drugs Market Competitive Situation and Trends 4.5.1 Diabetic Therapeutic Drugs Market Concentration Rate 4.5.2 Diabetic Therapeutic Drugs Market Share (%) of Top 3 and Top 5 Manufacturers 5 Global Diabetic Therapeutic Drugs Production by Regions (2012-2017) 5.1 Global Diabetic Therapeutic Drugs Capacity (K Units) and Market Share (%) by Regions (2012-2017) 5.2 Global Diabetic Therapeutic Drugs Production (K Units) and Market Share (%) by Regions (2012-2017) 5.3 Global Diabetic Therapeutic Drugs Revenue and Market Share (%) by Regions (2012-2017) 5.4 Global Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.5 North America Diabetic Therapeutic Drugs Production (2012-2017) 5.5.1 North America Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.5.2 North America Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.6 Europe Diabetic Therapeutic Drugs Production (2012-2017) 5.6.1 Europe Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.6.2 Europe Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.7 China Diabetic Therapeutic Drugs Production (2012-2017) 5.7.1 China Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.7.2 China Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.8 Japan Diabetic Therapeutic Drugs Production (2012-2017) 5.8.1 Japan Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.8.2 Japan Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.9 Southeast Asia Diabetic Therapeutic Drugs Production (2012-2017) 5.9.1 Southeast Asia Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.9.2 Southeast Asia Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 5.10 India Diabetic Therapeutic Drugs Production (2012-2017) 5.10.1 India Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) 5.10.2 India Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 6 Global Diabetic Therapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.1 Global Diabetic Therapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.2 North America Diabetic Therapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.3 Europe Diabetic Therapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.4 China Diabetic Therapeutic Drugs Consumption (K Units) by Regions (2012-2017) 6.5 Japan Diabetic Therapeutic Drugs Consumption (K Units) by Regions (2012-2017) 7 Global Diabetic Therapeutic Drugs Production, Revenue, Price Trend by Types 7.1 Global Diabetic Therapeutic Drugs Production (K Units) and Market Share (%) by Types (2012-2017) 7.2 Global Diabetic Therapeutic Drugs Revenue (Million USD) and Market Share (%) by Types (2012-2017) 7.3 Global Diabetic Therapeutic Drugs Price (USD/Unit) by Type (2012-2017) 7.4 Global Diabetic Therapeutic Drugs Production Growth (%) by Type (2012-2017) 8 Global Market Analysis by Applications 8.1 Global Consumption (K Units) and Market Share (%) by Applications (2012-2017) 8.2 Global Consumption Growth Rate by Applications (2012-2017) 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Global Diabetic Therapeutic Drugs Market Forecast (2018-2023) 10.1 Global Diabetic Therapeutic Drugs Capacity, Production, Revenue Forecast (2018-2023) 10.1.1 Global Diabetic Therapeutic Drugs Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) 10.1.2 Global Diabetic Therapeutic DrugsRevenue (Million USD) and Growth Rate (%) Forecast (2018-2023) 10.1.3 Global Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) 10.2 Global Diabetic Therapeutic Drugs Production (K Units) Forecast by Regions (2018-2023) 10.2.1 North America Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.2 Europe Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.3 China Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.4 Japan Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.5 Southeast Asia Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.2.6 India Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Forecast (2018-2023) 10.3 Global Diabetic Therapeutic Drugs Consumption (K Units) Forecast by Regions (2018-2023) 10.3.1 North America Diabetic Therapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.2 Europe Diabetic Therapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.3 China Diabetic Therapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.4 Japan Diabetic Therapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.5 Southeast Asia Diabetic Therapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.3.6 India Diabetic Therapeutic Drugs Consumption (K Units) Forecast (2018-2023) 10.4 Global Diabetic Therapeutic Drugs Production, Revenue and Price Forecast by Type (2018-2023) 10.5 Global Diabetic Therapeutic Drugs Consumption Forecast by Application (2018-2023) 11 Research Findings and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Disclaimer 12.4 Author List

List of Tables and Figures Figure Global Diabetic Therapeutic Drugs Market Size (Million USD) Status and Outlook 2012-2023 Table Diabetic Therapeutic Drugs Production (K Units) and Revenue (Million USD) Market Split by Product Type Table Diabetic Therapeutic Drugs Consumption (K Units) by Application (2017-2023) Figure Picture of Diabetic Therapeutic Drugs Figure Global Diabetic Therapeutic Drugs Production Market Share (%) by Types in 2016 Figure Global Diabetic Therapeutic Drugs Production Market Share (%) by Subclasses of Insulin Therapies in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Diabetic Therapeutic Drugs Production Market Share (%) by Subclasses of Non-Insulin Therapies in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Figure Global Diabetic Therapeutic Drugs Production Market Share (%) by Subclasses of in 2016 Figure Product Picture of Subclass 1 Table Major Manufacturers of Subclass 1 Figure Product Picture of Subclass 2 Table Major Manufacturers of Subclass 2 Figure Product Picture of Subclass 3 Table Major Manufacturers of Subclass 3 Table Global Diabetic Therapeutic Drugs Consumption (K Units) Comparison by Applications (2012-2023) Table Global Diabetic Therapeutic Drugs Consumption (USD/Unit) Market Share (%) by Applications in 2016 Figure Type 1 Diabetes Examples Figure Type 2 Diabetes Examples Figure Gestational Diabetes Examples Figure New Project SWOT Analysis of Diabetic Therapeutic Drugs Table Industry News List of Diabetic Therapeutic Drugs Figure Industry Chain Structure of Diabetic Therapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/Unit) Figure Global Raw Material B Price Trend (USD/Unit) Figure Global Raw Material C Price Trend (USD/Unit) Table Manufacturing Cost Structure Analysis of Diabetic Therapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Diabetic Therapeutic Drugs Table Raw Materials Sources of Diabetic Therapeutic Drugs Major Manufacturers in 2017 Table Major Buyers of Diabetic Therapeutic Drugs Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Pfizer Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Pfizer Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Diabetic Therapeutic Drugs Volume in ?Type 1 Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Pfizer Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Novartis Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Novartis Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Novartis Diabetic Therapeutic Drugs Volume in and Its Application Share Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors Table AstraZeneca Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure AstraZeneca Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table AstraZeneca Diabetic Therapeutic Drugs Volume in and Its Application Share Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Eli Lilly Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Eli Lilly Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Eli Lilly Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Eli Lilly Diabetic Therapeutic Drugs Volume in and Its Application Share Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Merck Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Merck Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Merck Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Novo Nordisk Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Novo Nordisk Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Type 1 Diabetes and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in and Its Application Share Table Novo Nordisk Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Sanofi Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Sanofi Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi Diabetic Therapeutic Drugs Volume in ?Type 1 Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Sanofi Diabetic Therapeutic Drugs Volume in and Its Application Share Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in ?Type 1 Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table F. Hoffmann-La Roche Diabetic Therapeutic Drugs Volume in and Its Application Share Table Takeda Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Takeda Pharmaceuticals Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in ?Type 1 Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Takeda Pharmaceuticals Diabetic Therapeutic Drugs Volume in and Its Application Share Table Sun Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors Table Sun Pharma Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2012-2017) Figure Sun Pharma Diabetic Therapeutic Drugs Production Growth Rate (%) (2012-2017) Figure Sun Pharma Diabetic Therapeutic Drugs Production Market Share (%) (2012-2017) Figure Sun Pharma Diabetic Therapeutic Drugs Revenue Market Share (%) (2012-2017) Table Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Non-Insulin Therapies Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Production (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sun Pharma Diabetic Therapeutic Drugs Volume in ?Type 1 Diabetes and Its Application Share Table Sun Pharma Diabetic Therapeutic Drugs Volume in Type 2 Diabetes and Its Application Share Table Sun Pharma Diabetic Therapeutic Drugs Volume in Gestational Diabetes and Its Application Share Table Sun Pharma Diabetic Therapeutic Drugs Volume in and Its Application Share Table Global Diabetic Therapeutic Drugs Capacity (K Units) of Key Manufacturers (2012-2017) Table Global Diabetic Therapeutic Drugs Capacity Market Share (%) of Key Manufacturers (2012-2017) Figure Global Diabetic Therapeutic Drugs Capacity Market Share (%) of Key Manufacturers in 2017 Figure Global Diabetic Therapeutic Drugs Capacity Market Share (%) of Key Manufacturers in 2017 Table Global Diabetic Therapeutic Drugs Production (K Units) of Key Manufacturers (2012-2017) Table Global Diabetic Therapeutic Drugs Production Share (%) by Manufacturers (2012-2017) Figure 2016 Diabetic Therapeutic Drugs Production Share (%) by Manufacturers Figure 2016 Diabetic Therapeutic Drugs Production Share (%) by Manufacturers Table Global Diabetic Therapeutic Drugs Revenue (Million USD) by Manufacturers (2012-2017) Table Global Diabetic Therapeutic Drugs Revenue Share (%) by Manufacturers (2012-2017) Table 2016 Global Diabetic Therapeutic Drugs Revenue Share (%) by Manufacturers Table 2016 Global Diabetic Therapeutic Drugs Revenue Share (%) by Manufacturers Table Global Market Diabetic Therapeutic Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017) Figure Global Market Diabetic Therapeutic Drugs Average Price (USD/Unit) of Key Manufacturers in 2017 Table Manufacturers Diabetic Therapeutic Drugs Manufacturing Base Distribution and Sales Area Table Manufacturers Diabetic Therapeutic Drugs Product Category Figure Diabetic Therapeutic Drugs Market Share (%) of Top 3 Manufacturers Figure Diabetic Therapeutic Drugs Market Share (%) of Top 5 Manufacturers Table Global Diabetic Therapeutic Drugs Capacity (K Units) by Regions (2012-2017) Figure Global Diabetic Therapeutic Drugs Capacity Market Share (%) by Regions (2012-2017) Figure Global Diabetic Therapeutic Drugs Capacity Market Share (%) by Regions (2012-2017) Figure 2016 Global Diabetic Therapeutic Drugs Capacity Market Share (%) by Regions Table Global Diabetic Therapeutic Drugs Production (K Units) by Regions (2012-2017) Figure Global Diabetic Therapeutic Drugs Production Market Share (%) by Regions (2012-2017) Figure Global Diabetic Therapeutic Drugs Production Market Share (%) by Regions (2012-2017) Figure 2016 Global Diabetic Therapeutic Drugs Production Market Share (%) by Regions Table Global Diabetic Therapeutic Drugs Revenue (Million USD) by Regions (2012-2017) Table Global Diabetic Therapeutic Drugs Revenue Market Share (%) by Regions (2012-2017) Figure Global Diabetic Therapeutic Drugs Revenue Market Share (%) by Regions (2012-2017) Figure 2016 Global Diabetic Therapeutic Drugs Revenue Market Share (%) by Regions Figure Global Diabetic Therapeutic Drugs Capacity, Production (K Units) and Growth Rate (2012-2017) Table Global Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure North America Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table North America Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Europe Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table Europe Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure China Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table China Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Japan Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) (2012-2017) Table Japan Diabetic Therapeutic Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Table Global Diabetic Therapeutic Drugs Consumption (K Units) Market by Regions (2012-2017) Table Global Diabetic Therapeutic Drugs Consumption Market Share (%) by Regions (2012-2017) Figure Global Diabetic Therapeutic Drugs Consumption Market Share (%) by Regions (2012-2017) Figure 2016 Global Diabetic Therapeutic Drugs Consumption Market Share (%) by Regions Figure North America Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Europe Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure China Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Japan Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Southeast Asia Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure India Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure South America Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Figure Middle East Diabetic Therapeutic Drugs Consumption and Growth Rate (%) (2012-2017) Table Global Diabetic Therapeutic Drugs Production (K Units) by Types (2012-2017) Table Global Diabetic Therapeutic Drugs Production Share (%) by Types (2012-2017) Figure Production Market Share (%) of Diabetic Therapeutic Drugs by Types (2012-2017) Figure 2016 Production Market Share (%) of Diabetic Therapeutic Drugs by Types Table Global Diabetic Therapeutic Drugs Revenue (Million USD) by Types (2012-2017) Table Global Diabetic Therapeutic Drugs Revenue Share (%) by Types (2012-2017) Figure Revenue Share (%) of Diabetic Therapeutic Drugs by Types (2012-2017) Figure 2016 Revenue Market Share (%) of Diabetic Therapeutic Drugs by Types Table Global Diabetic Therapeutic Drugs Price (USD/Unit) by Types (2012-2017) Figure Global Diabetic Therapeutic Drugs Production Growth (%) by Type (2012-2017) Table Global Diabetic Therapeutic Drugs Consumption (K Units) by Applications (2012-2017) Table Global Diabetic Therapeutic Drugs Consumption Market Share (%) by Applications (2012-2017) Figure Global Diabetic Therapeutic Drugs Consumption Market Share (%) by Applications (2012-2017) Figure Global Diabetic Therapeutic Drugs Consumption Market Share (%) by Applications in 2017 Table Global Diabetic Therapeutic Drugs Consumption Growth Rate by Applications (2012-2017) Figure Global Diabetic Therapeutic Drugs Consumption Growth Rate by Applications (2012-2017) Table Distributors/Traders List Figure Global Diabetic Therapeutic Drugs Capacity, Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Global Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Global Diabetic Therapeutic Drugs Price and Trend Forecast (2018-2023) Table Global Diabetic Therapeutic Drugs Production (K Units) Forecast by Regions (2018-2023) Figure Global Diabetic Therapeutic Drugs Production Market Share (%) Forecast by Regions (2018-2023) Figure North America Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North America Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Diabetic Therapeutic Drugs Production (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Japan Diabetic Therapeutic Drugs Production (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Diabetic Therapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Global Diabetic Therapeutic Drugs Consumption (K Units) Forecast by Regions (2018-2023) Figure Global Diabetic Therapeutic Drugs Consumption Market Share (%) Forecast by Regions (2018-2023) Figure North America Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Europe Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure China Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Japan Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southeast Asia Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure India Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South America Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Middle East Diabetic Therapeutic Drugs Consumption (K Units) and Growth Rate (%) Forecast (2018-2023) Table Global Diabetic Therapeutic Drugs Production (K Units) Forecast by Type (2018-2023) Figure Global Diabetic Therapeutic Drugs Production Forecast by Type (2018-2023) Table Global Diabetic Therapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Global Diabetic Therapeutic Drugs Revenue Market Share (%) Forecast by Type (2018-2023) Table Global Diabetic Therapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Global Diabetic Therapeutic Drugs Consumption (K Units) Forecast by Application (2018-2023) Figure Global Diabetic Therapeutic Drugs Consumption Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Pfizer Novartis AstraZeneca Eli Lilly Merck Novo Nordisk Sanofi F. Hoffmann-La Roche Takeda Pharmaceuticals Sun Pharma Perle Biosciences Arbutus Biopharma Belrose Pharma Mitsubishi Tanabe Pharma Dong-A ST